Role of statin in atrial fibrillation-related stroke: An angiographic study for collateral flow

Cerebrovascular Diseases

Volumn 37, Issue 2, 2014, Pages 77-84

  Lee, Mi Ji ^a   Bang, Oh Young ^a   Kim, Suk Jae ^a   Kim, Gyeong Moon ^a   Chung, Chin Sang ^a   Lee, Kwang Ho ^a   Ovbiagele, Bruce ^b   Liebeskind, David S ^c   Saver, Jeffrey L ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

Arteriogenesis; Atrial fibrillation; Collateral flow; Statin; Stroke

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ATORVASTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ANGIOGRAPHY; CARDIOEMBOLIC STROKE; CEREBRAL ARTERY DISEASE; COLLATERAL CIRCULATION; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH KOREA; UNITED STATES; ATRIAL FIBRILLATION; BRAIN INFARCTION; MIDDLE CEREBRAL ARTERY OCCLUSION;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; COLLATERAL CIRCULATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE;

EID: 84892699116     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000356114     Document Type: Article

References (36)

1. Kwee RM, van Oostenbrugge RJ, Prins MH, Ter Berg JW, Franke CL, Korten AG, Meems BJ, van Engelshoven JM, Wildberger JE, Mess WH, Kooi ME: Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 2010; 41:1389-1393.
2. Otagiri K, Tsutsui H, Kumazaki S, Miyashita Y, Aizawa K, Koshikawa M, Kasai H, Izawa A, Tomita T, Koyama J: Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study). Circ J 2011; 75:633.
3. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wen-tworth D: Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:227-276.
4. Bang OY, Ovbiagele B, Liebeskind DS, Restre-po L, Yoon SR, Saver JL: Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke. J Neurol 2009; 256: 591-599.
5. Muscari A, Puddu GM, Santoro N, Serafini C, Cenni A, Rossi V, Zoli M: The atorvastatin during ischemic stroke study: a pilot randomized controlled trial. Clin Neuropharmacol 2011; 34:141-147.
6. Ni Chroinin D, Callaly EL, Duggan J, Mer-wick A, Hannon N, Sheehan O, Marnane M, Horgan G, Williams EB, Harris D, Kyne L, McCormack PM, Moroney J, Grant T, Williams D, Daly L, Kelly PJ: Association between acute statin therapy, survival, and improved functional outcome after ischemic stroke: the North Dublin Population Stroke Study. Stroke 2011; 42:1021-1029.
7. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355:549-559.
8. Bang OY, Saver JL, Buck BH, Alger JR, Stark-man S, Ovbiagele B, Kim D, Jahan R, Duck-wiler GR, Yoon SR, Vinuela F, Liebeskind DS: Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008; 79:625-629.
9. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, Lee KH, Liebeskind DS: Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke 2011; 42:693-699.
10. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, Lee KH, Liebeskind DS: Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke 2011; 42: 2235-2239.
11. Ovbiagele B, Saver JL, Starkman S, Kim D, Ali LK, Jahan R, Duckwiler GR, Vinuela F, Pineda S, Liebeskind DS: Statin enhancement of collateralization in acute stroke. Neurology 2007; 68:2129-2131.
12. Pourati I, Kimmelstiel C, Rand W, Karas RH: Statin use is associated with enhanced collat-eralization of severely diseased coronary arteries. Am Heart J 2003; 146:876-881.
13. Ay H, Furie KL, Singhal A, Smith WS, So-rensen AG, Koroshetz WJ: An evidence-based causative classification system for acute isch-emic stroke. Ann Neurol 2005; 58:688-697.
14. Jones P, Kafonek S, Laurora I, Hunninghake D: Comparative dose efficacy study of atorv-astatin versus simvastatin, pravastatin, lovas-tatin, and fluvastatin in patients with hyper-cholesterolemia (the CURVES study). Am J Cardiol 1998; 81:582-587.
15. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34:e109-e137.
16. Tu HT, Campbell BC, Christensen S, Collins M, De Silva DA, Butcher KS, Parsons MW, Desmond PM, Barber PA, Levi CR, Bladin CF, Donnan GA, Davis SM: Pathophysiologi-cal determinants of worse stroke outcome in atrial fibrillation. Cerebrovasc Dis 2010; 30: 389-395.
17. Soares BP, Chien JD, Wintermark M: MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recan-alizes does not necessarily reperfuse! Stroke 2009; 40:S24-S27.
18. Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T: Atrial fibrillation as an independent predictor for no early recana-lization after IV-t-PA in acute ischemic stroke. J Neurol Sci 2008; 267:57-61.
19. Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA: Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis. Arch Neurol 2011; 68:1454-1458.
20. Maas MB, Lev MH, Ay H, Singhal AB, Greer DM, Smith WS, Harris GJ, Halpern E, Kem-mling A, Koroshetz WJ: Collateral vessels on CT angiography predict outcome in acute ischemic stroke. Stroke 2009; 40:3001-3005.
21. Flint AC, Kamel H, Navi BB, Rao VA, Faigeles BS, Conell C, Klingman JG, Sidney S, Hills NK, Sorel M, Cullen SP, Johnston SC: Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke 2012; 43:147-154.
22. Zbinden S, Brunner N, Wustmann K, Bill-inger M, Meier B, Seiler C: Effect of statin treatment on coronary collateral flow in patients with coronary artery disease. Heart 2004; 90:448-449.
23. Boodhwani M, Mieno S, Feng J, Sodha NR, Clements RT, Xu SH, Sellke FW: Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine. J Thorac Cardiovasc Surg 2008; 135: 117-122.
24. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feld-kamp CS, Chopp M: Statins induce angiogen-esis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003; 53:743-751.
25. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, Sessa WC, Walsh K: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angio-genesis in normocholesterolemic animals. Nat Med 2000; 6:1004-1010.
26. Weis M, Heeschen C, Glassford AJ, Cooke JP: Statins have biphasic effects on angiogenesis. Circulation 2002; 105:739-745.
27. Hibbert B, Ma X, Pourdjabbar A, Simard T, Rayner K, Sun J, Chen YX, Filion L, O'Brien ER: Pre-procedural atorvastatin mobilizes en-dothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries. PLoS One 2011; 6:e16413.
28. Jaumdally RJ, Goon PK, Varma C, Blann AD, Lip GY: Effects of atorvastatin on circulating CD34+/CD133+/CD45-progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. J Intern Med 2010; 267:385-393.
29. Tongers J, Roncalli JG, Losordo DW: Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc Res 2010; 79:200-206.
30. Van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W: Stimulation of arte-riogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001; 49:543-553.
31. Zacharek A, Chen J, Cui X, Yang Y, Chopp M: Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke. Stroke 2009; 40:254-260.
32. Grundmann S, Piek JJ, Pasterkamp G, Hoefer IE: Arteriogenesis: basic mechanisms and therapeutic stimulation. Eur J Clin Invest 2007; 37:755-766.
33. Ford AL, An H, D'Angelo G, Ponisio R, Bush-ard P, Vo KD, Powers WJ, Lin W, Lee JM: Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke. Stroke 2011; 42:1307-1313.
34. Jorge PA, Osaki MR, de Almeida E: Rapid reversal of endothelial dysfunction in hyper-cholesterolaemic rabbits treated with simvas-tatin and pravastatin. Clin Exp Pharmacol Physiol 1997; 24:948-953.
35. Montaner J, Chacon P, Krupinski J, Rubio F, Millan M, Molina CA, Hereu P, Quintana M, Alvarez-Sabin J: Simvastatin in the acute phase of ischemic stroke: A safety and efficacy pilot trial. Eur J Neurol 2008; 15:82-90.
36. Biffi A, Devan WJ, Anderson CD, Cortellini L, Furie KL, Rosand J, Rost NS: Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke 2011; 42:1314-1319.